More about NATCO Pharma Limited

Technicals for NATCO Pharma Limited

With the K-line positioned above the D-line and under 20 on the...

NATCOPHARM's forward EPS being lower than trailing EPS indicates reduced profitability in...

The list of all important regulatory filings for NATCO Pharma Limited which...

An analysis of the potential impacts of the Trump-Putin summit in Alaska...

The Alaska Summit on August 15, 2025, is anticipated to significantly influence...

The article analyzes the potential impacts of the upcoming Trump–Putin summit on...

Last Updated:

2025-08-13 21:27

Published	Title	Summary
2025-07-25 17:06:34	Acquisition-XBRL	NATCO PHARMA LIMITED has informed the Exchange regarding Acquisition...
NATCO PHARMA LIMITED has informed the Exchange regarding Acquisition
2025-01-30 16:38:38	Board Meeting Intimation	NATCO PHARMA LIMITED has informed the Exchange about Board Meeting...
NATCO PHARMA LIMITED has informed the Exchange about Board Meeting to be held on 12-Feb-2025 to consider and approve the Quarterly Unaudited Financial results of the Company for the period ended December 2024 and Dividend.
2024-08-12 14:07:44	Dividend	Natco Pharma Limited has informed the Exchange that Board of...
Natco Pharma Limited has informed the Exchange that Board of Directors at its meeting held on August 12, 2024, considered Unaudited Financial Results for the quarter ended 30th June, 2024 and declared Interim Dividend of Rs. 3.00 per equity share along with other Agenda Items
2024-07-26 16:06:49	Board Meeting Intimation	NATCO PHARMA LIMITED has informed the Exchange about Board Meeting...
NATCO PHARMA LIMITED has informed the Exchange about Board Meeting to be held on 12-Aug-2024 to consider and approve the Quarterly Unaudited Financial results of the Company for the period ended June 2024 and Dividend.